Atkins Confirmed By U.S. Senate to Take Over SEC Formerly Run by Gensler

Corriente Biotechnology Partners

investment firm

About

Corriente Biotechnology Partners was added in 2010.

Details

Operating Status
Active
Investor Type
PE

Investments

Number of Investments
Number of Lead Investments
1
0
Corriente Biotechnology Partners has made 1 investments. Their most recent investment was on Feb 17, 2005, when FibroGen raised $100M.
Date Company Name
Round Money Raised Industry Lead Investor
Feb 17, 2005 FibroGen
Series Unknown $100M Biopharma

Exits

Corriente Biotechnology Partners has had 1 exits. Corriente Biotechnology Partners most notable exits include FibroGen

Date Company Name Exit Type Industry
Nov 21, 2014 FibroGen IPO Biopharma Detail